US Patent Issued to Ferring on Nov. 25 for "Human-derived recombinant FSH for controlled ovarian" (Danish Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,660, issued on Nov. 25, was assigned to Ferring B.V. (Hoofddorp, Netherlands).

"Human-derived recombinant FSH for controlled ovarian" was invented by Joan-Carles Arce (Dragor, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility."

The patent was filed on March 30, 2022, under Application No. 17/709,305.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12478660&OS=12478660&RS=12478660 ...